Additionally, a study involving 20 cases of DEPDC5-related epilepsy phenotypes found that medications such as lamotrigine and sodium valproate achieved favorable therapeutic outcomes in some patients (Liu et al., 2021). The gene discussed is DEPDC5; the disease is epilepsy.